Serum Adiponectin Predicts COVID-19 Severity

被引:2
作者
Pavel, Vlad [1 ]
Raeth, Ulrich [1 ]
Schmid, Stephan [1 ]
Krautbauer, Sabrina [2 ]
Keller, Dennis [1 ]
Amend, Pablo [1 ]
Mueller, Martina [1 ]
Mester, Patricia [1 ]
Buechler, Christa [1 ]
机构
[1] Univ Hosp Regensburg, Dept Internal Med Gastroenterol Hepatol Endocrinol, D-93053 Regensburg, Germany
[2] Univ Hosp Regensburg, Inst Clin Chem & Lab Med, D-93053 Regensburg, Germany
关键词
adiponectin; disease severity; C-reactive protein; intensive care; bacterial superinfection; COVID-19; ADIPOSE-TISSUE; EXPRESSION; MORTALITY; MARKERS; OBESITY; SEPSIS;
D O I
10.3390/biomedicines12051043
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Adiponectin is primarily known for its protective role in metabolic diseases, and it also possesses immunoregulatory properties. Elevated levels of adiponectin have been observed in various inflammatory diseases. However, studies investigating adiponectin levels in the serum of COVID-19 patients have yielded conflicting results. This study aimed to assess serum adiponectin levels in 26 healthy controls, as well as in 64 patients with moderate and 60 patients with severe COVID-19, to determine a potential association between serum adiponectin and the severity of COVID-19. Serum adiponectin levels in severe COVID-19 patients were significantly lower than in those with moderate disease and healthy controls, who exhibited similar serum adiponectin levels. Among patients with moderate disease, positive correlations were observed between serum adiponectin and C-reactive protein levels. Of note, serum adiponectin levels of severe COVID-19 cases were comparable between patients with and without dialysis or vasopressor therapy. Superinfection with bacteria did not exert a notable influence on serum adiponectin levels in patients with severe disease. Patients who were diagnosed with severe COVID-19 and vancomycin-resistant enterococci bacteremia showed a significant reduction in their serum adiponectin levels. An analysis conducted on the entire cohort, including both moderate and severe COVID-19 patients, showed that individuals who did not survive had lower serum adiponectin levels when compared to those who survived. In summary, this study highlights a decrease in serum adiponectin levels in severe COVID-19 cases, indicating the potential utility of adiponectin as an additional biomarker for monitoring disease severity in COVID-19 or critical illnesses in general.
引用
收藏
页数:15
相关论文
共 71 条
  • [61] Sars-Cov2 Induced Biochemical Mechanisms in Liver Damage and Intestinal Lesions
    Spirina, Liudmila, V
    Masunov, Vladimir N.
    Dyakov, Denis A.
    Akbasheva, Olga E.
    Kebekbayeva, Amina Y.
    Shuvalov, Igor Yu
    Masunova, Nadezhda, V
    Kovaleva, Irina, V
    Dagbaeva, Yumzhana
    [J]. INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2023, 38 (04) : 437 - 446
  • [62] Chemerin as a Potential Marker of Resolution of Inflammation in COVID-19 Infection
    Sulicka-Grodzicka, Joanna
    Surdacki, Andrzej
    Surmiak, Marcin
    Sanak, Marek
    Wizner, Barbara
    Sydor, Wojciech
    Strach, Magdalena
    Korkosz, Mariusz
    Skladany, Lubomir
    Grgurevic, Ivica
    Podrug, Kristian
    Kukla, Michal
    Bociasa-Jasik, Monika
    [J]. BIOMEDICINES, 2022, 10 (10)
  • [63] Adiponectin: mechanistic insights and clinical implications
    Turer, A. T.
    Scherer, P. E.
    [J]. DIABETOLOGIA, 2012, 55 (09) : 2319 - 2326
  • [64] Changes in serum adiponectin concentrations in critical illness: a preliminary investigation
    Venkatesh, Bala
    Hickman, Ingrid
    Nisbet, Janelle
    Cohen, Jeremy
    Prins, John
    [J]. CRITICAL CARE, 2009, 13 (04):
  • [65] Plasma adiponectin levels and type 2 diabetes risk: a nested case-control study in a Chinese population and an updated meta-analysis
    Wang, Yeli
    Meng, Rui-Wei
    Kunutsor, Setor K.
    Chowdhury, Rajiv
    Yuan, Jian-Min
    Koh, Woon-Puay
    Pan, An
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [66] Impaired hepatic removal of interleukin-6 in patients with liver cirrhosis
    Wiest, Reiner
    Weigert, Johanna
    Wanninger, Josef
    Neumeier, Markus
    Bauer, Sabrina
    Schmidhofer, Sandra
    Farkas, Stefan
    Scherer, Marcus N.
    Schaeffler, Andreas
    Schoelmerich, Juergen
    Buechler, Christa
    [J]. CYTOKINE, 2011, 53 (02) : 178 - 183
  • [67] Association between Reduction of Plasma Adiponectin Levels and Risk of Bacterial Infection after Gastric Cancer Surgery
    Yamamoto, Hiroshi
    Maeda, Kazuhisa
    Uji, Yoshitaka
    Tsuchihashi, Hiroshi
    Mori, Tsuyoshi
    Shimizu, Tomoharu
    Endo, Yoshihiro
    Kadota, Aya
    Miura, Katsuyuki
    Koga, Yusuke
    Ito, Toshinori
    Tani, Tohru
    [J]. PLOS ONE, 2013, 8 (03):
  • [68] A Review of Detection Methods for Vancomycin-Resistant Enterococci (VRE) Genes: From Conventional Approaches to Potentially Electrochemical DNA Biosensors
    Zakaria, Nor Dyana
    Hamzah, Hairul Hisham
    Salih, Ibrahim Luqman
    Balakrishnan, Venugopal
    Abdul Razak, Khairunisak
    [J]. BIOSENSORS-BASEL, 2023, 13 (02):
  • [69] The effect of thiazolidinediones on body fat redistribution in adults: A systematic review and meta-analysis of randomized controlled trials
    Zhang, Fang
    Pan, Xiaohui
    Zhang, Xinyue
    Tong, Nanwei
    [J]. OBESITY REVIEWS, 2024, 25 (03)
  • [70] Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
    Zsichla, Levente
    Mueller, Viktor
    [J]. VIRUSES-BASEL, 2023, 15 (01):